In Brief
This article was originally published in The Rose Sheet
Executive Summary
With earnings season in full swing, Shiseido reports sales down just over 1% for the first nine months of fiscal 2012, while sales at Inter Parfums advanced more than 6% for its fiscal year ended December 31. More news in brief.
You may also be interested in...
NY Elements Show Comes Down To Earth With Natural Scents
The Jan. 28-29 edition of Elements Showcase in New York saw a growing selection of natural and organic creations in fragrance and other beauty categories.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.